BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33694031)

  • 1. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
    Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of ayahuasca administered in two repeated doses.
    Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
    Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
    Hamill J; Hallak J; Dursun SM; Baker G
    Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
    Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.
    Uthaug MV; van Oorsouw K; Kuypers KPC; van Boxtel M; Broers NJ; Mason NL; Toennes SW; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2018 Oct; 235(10):2979-2989. PubMed ID: 30105399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life.
    Kaasik H; Kreegipuu K
    J Psychoactive Drugs; 2020; 52(3):255-263. PubMed ID: 32299306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series.
    Gómez-Sousa M; Jiménez-Garrido DF; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):163-171. PubMed ID: 33606432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
    Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
    J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users.
    Ona G; Kohek M; Massaguer T; Gomariz A; Jiménez DF; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
    J Psychoactive Drugs; 2019; 51(2):135-145. PubMed ID: 30732540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders.
    Lafrance A; Loizaga-Velder A; Fletcher J; Renelli M; Files N; Tupper KW
    J Psychoactive Drugs; 2017; 49(5):427-435. PubMed ID: 28895501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users.
    Ramaekers JG; Mallaroni P; Kloft L; Reckweg JT; Toennes SW; van Oorsouw K; Mason NL
    J Cogn Neurosci; 2023 Sep; 35(9):1382-1393. PubMed ID: 37159257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.
    Frecska E; Móré CE; Vargha A; Luna LE
    J Psychoactive Drugs; 2012; 44(3):191-9. PubMed ID: 23061318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
    Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
    J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effects of ayahuasca on personality structure in a traditional framework.
    Netzband N; Ruffell S; Linton S; Tsang WF; Wolff T
    Psychopharmacology (Berl); 2020 Oct; 237(10):3161-3171. PubMed ID: 32700023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in spirituality among ayahuasca ceremony novice participants.
    Trichter S; Klimo J; Krippner S
    J Psychoactive Drugs; 2009 Jun; 41(2):121-34. PubMed ID: 19705674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
    Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
    Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
    Gable RS
    Addiction; 2007 Jan; 102(1):24-34. PubMed ID: 17207120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.
    Orsolini L; Chiappini S; Papanti D; Latini R; Volpe U; Fornaro M; Tomasetti C; Vellante F; De Berardis D
    Hum Psychopharmacol; 2020 May; 35(3):e2728. PubMed ID: 32220028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
    Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
    Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.